InVivo Therapeutics Holdings's current assets is $9.5M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
InVivo Therapeutics Holdings (NVIV) currently reports a current assets of $9.5M as of September 2023. That compares with $12M in the prior-year period — down 17.6% year over year. Use the charts on this page to explore InVivo Therapeutics Holdings's current assets history and peer comparisons.
InVivo Therapeutics Holdings's current assets decreased from $12M to $9.5M — a 17.6% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
InVivo Therapeutics Holdings reported $9.5M in current assets as of September 2023. That compares with $12M in the prior-year period — down 17.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $9.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for InVivo Therapeutics Holdings, and consider following NVIV for alerts when major investors trade the stock.
InVivo Therapeutics Holdings is classified in the Healthcare sector. On current assets, it currently shows $9.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NVIV with unrelated industries.